investigators analyzed updated data on the effects of prenatal myelomeningocele closure on the need for placement of a cerebrospinal fluid (CSF) shunt within the first 12 months of life.

Most infants with myelomeningocele have hydrocephalus and require surgical treatment. There is currently little agreement among leading practitioners about the optimal timing of closure of the ...

All three had undergone in utero closure of myelomeningocele at one institution. The preoperative evaluation and in utero treatment of the three patients have been described previously.

It is a neural tube defect. There are four main types of spina bifida: myelomeningocele spina bifida occulta closed neural tube defects meningocele Myelomeningocele is the most severe type.

as a result of failed closure or formation of the embryonic neural tube. The most common and severe form is myelomeningocele (also termed open spina bifida or spina bifida aperta) (Fig.

(March 17 issue), 1 a randomized trial comparing the efficacy of prenatal repair of myelomeningocele with that of postnatal repair, Adzick et al. state that prenatal closure reduced the need for ...

Any birth defect involving incomplete closure of the spine results in ... nerves and meninges during the first month of pregnancy. Myelomeningocele is the most severe and the most common form ...

Myelomeningocele is a neural tube defect affecting many systems in the human body and requiring multidisciplinary medical care to ensure optimal function and quality of life as well as survival of ...

These data suggest the underlying genetic basis for closed defects may be the same or closely related to that for myelomeningocele in some families, although a larger sample will be necessary ...

Myelomeningocele may cause loss of movement in the legs, and bladder and bowel dysfunction. —VAL, GMA Integrated News This article PCMC announces PH's first successful open fetal surgery was ...

investigators analyzed updated data on the effects of prenatal myelomeningocele closure on the need for placement of a cerebrospinal fluid (CSF) shunt within the first 12 months of life.